Pipeline Embolization Device (PED)
Device1 or more PEDs placed in the parent artery of the affected aneurysm via endovascular approach
NCT Number: NCT00777088
To determine the safety and effectiveness of Pipeline Embolization Device for the treatment of uncoilable or failed wide-necked intracranial aneurysms (IA).
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Not applicable
National Institute of Neurosurgery, Budapest, Hungary
Patients with large or giant aneurysms of the internal carotid artery treated with PED. Angiographic follow-up occurs at 3 and 5 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
a) Is located in the following regions of the internal carotid artery: i. Paraophthalmic (including paraclinoid, ophthalmic and hypophyseal segments) ii. Cavernous iii. Petrous
b) Has a neck >4 mm or no discernible neck AND a size (maximum fundus diameter) >10 mm
c) Has a parent vessel with diameter 2.5 - 5.0 mm distal/proximal to the target IA
Exclusion criteria
1 or more PEDs placed in the parent artery of the affected aneurysm via endovascular approach
Time frame: 180-days and 5-years
The number of participants with occurrence of major ipsilateral stroke or neurologic death after PED placement at 180-days and the occurrence of ipsilateral stroke or neurologic death after Pipeline Embolization Devices (PED) placement at 5-years.
Time frame: 180 days
The count of Intracranial Aneurysms (IA) evaluated as completely occluded (defined as Raymond Grade 1) without major parent artery stenosis at 180 days. The Raymond-Roy Grade scale measures the amount of visual contrast flow throughout the aneurysm anatomy. The Raymond-Roy aneurysm occlusion scale is follows:
Complete = complete occlusion, no flow of contrast seen in the sac Residual Neck = partial occlusion, some flow, or eddying flow, in the sac Residual Aneurysm = incomplete occlusion, apparent flow into the sac
Time frame: 1 Year
The count of Intracranial Aneurysms (IA) Evaluated as Completely Occluded (100%) (defined as Raymond-Roy grade 1) 1 year follow-up visit. The Raymond-Roy Grade scale measures the amount of visual contrast flow throughout the aneurysm anatomy. The Raymond-Roy aneurysm occlusion scale is follows:
Complete = complete occlusion, no flow of contrast seen in the sac Residual Neck = partial occlusion, some flow, or eddying flow, in the sac Residual Aneurysm = incomplete occlusion, apparent flow into the sac
Time frame: 3 years
The count of Intracranial Aneurysms (IA) evaluated as completely occluded (100%) (defined as Raymond-Roy grade 1) at 3 year follow-up. The Raymond-Roy Grade scale measures the amount of visual contrast flow throughout the aneurysm anatomy. The Raymond-Roy aneurysm occlusion scale is follows:
Complete = complete occlusion, no flow of contrast seen in the sac Residual Neck = partial occlusion, some flow, or eddying flow, in the sac Residual Aneurysm = incomplete occlusion, apparent flow into the sac
Time frame: 5 years
The count of Intracranial Aneurysms (IA) evaluated as completely occluded (100%) (defined as Raymond-Roy grade 1) at 5-year follow-up. The Raymond-Roy Grade scale measures the amount of visual contrast flow throughout the aneurysm anatomy. The Raymond-Roy aneurysm occlusion scale is follows:
Complete = complete occlusion, no flow of contrast seen in the sac Residual Neck = partial occlusion, some flow, or eddying flow, in the sac Residual Aneurysm = incomplete occlusion, apparent flow into the sac
Time frame: 3-years
Parent artery stenosis (narrowing of the artery from which the aneurysm arises) at 3-year follow-up
Time frame: 5-years
Parent artery stenosis at 5-year follow-up
Time frame: 3 years
Number of participants with incidence of device-related adverse events at 3 year follow-up
Time frame: 5 years
Subjects Observed with Device Related Adverse Events 5 years after Pipeline Placement
Medtronic Neurovascular Clinical Affairs
Industry
Acronym: PUFS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06303063
Aneurysm, Brain Diseases
Beijing, China
View Trial DetailsNCT04380350
Aneurysm, Brain Diseases
Salzburg, Austria
View Trial DetailsNCT07500155
AV Fistula, AVM - Cerebral Arteriovenous Malformation
Xingtai, China
View Trial DetailsNCT04518670
Aneurysm, Brain Diseases
Mobile, Alabama, United States
View Trial Details